The dogma of aspirin: a critical review of evidence on the best monotherapy after dual antiplatelet therapy

Dual antiplatelet therapy based on the combination of an adenosine diphosphate (ADP)-receptor antagonist plus aspirin has demonstrated to be more effective in reducing the rate of major ischemic vascular events compared to aspirin monotherapy in some clinical settings. The current controversy on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Polo Friz, Hernan, Molteni, Mauro, Cimminiello, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561422/
https://www.ncbi.nlm.nih.gov/pubmed/26347594
http://dx.doi.org/10.1186/s12959-015-0059-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561422/
https://www.ncbi.nlm.nih.gov/pubmed/26347594
http://dx.doi.org/10.1186/s12959-015-0059-8

Ejemplares similares